2022
DOI: 10.1016/j.humpath.2022.10.005
|View full text |Cite
|
Sign up to set email alerts
|

Lymphoplasmacytic lymphoma with IgG or IgA paraprotein: a study of 29 cases including cases that can mimic plasma cell neoplasms

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
9
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(9 citation statements)
references
References 19 publications
0
9
0
Order By: Relevance
“…Flow cytometry analysis of the B lymphocytes and plasma cells from non-IgM LPL consistently show monotypic concordant immunoglobulin light chain expression between these 2 components. In one series study [ 6 ], the neoplastic plasma cells defined by bright CD38 and CD138 were almost always positive for CD45 (100%, 26/26) and CD19 (96%, 25/26), while only partial/weak positive for CD56 (16%, 4/25), and negative for CD117 (100%, 24/24). In contrast, plasma cell neoplasm cells commonly show loss of CD19 and CD45 and gain of aberrant expression of CD56 and CD117 in about 70% and 30% cases, respectively.…”
Section: Discussionmentioning
confidence: 99%
See 4 more Smart Citations
“…Flow cytometry analysis of the B lymphocytes and plasma cells from non-IgM LPL consistently show monotypic concordant immunoglobulin light chain expression between these 2 components. In one series study [ 6 ], the neoplastic plasma cells defined by bright CD38 and CD138 were almost always positive for CD45 (100%, 26/26) and CD19 (96%, 25/26), while only partial/weak positive for CD56 (16%, 4/25), and negative for CD117 (100%, 24/24). In contrast, plasma cell neoplasm cells commonly show loss of CD19 and CD45 and gain of aberrant expression of CD56 and CD117 in about 70% and 30% cases, respectively.…”
Section: Discussionmentioning
confidence: 99%
“…The gene mutation data in non-IgM LPL is relatively scarce, and recent studies suggest MYD88 and CXCR4 mutations are possibly the 2 most recurrent gene mutations, similar to WM. Limited data indicate the prevalence of a MYD88 mutation in non-IgM LPL is about 43% to 80%, appearing to be lower than in WM [ 1 4 , 6 ]. Approximately 25% to 33% of the non-IgM LPL cases harbor a CXCR4 mutation, which frequently co-occurs with MYD88 mutation (67–75% concurrence rate) [ 3 , 6 ].…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations